Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Board and Senior Management Changes

28 Aug 2018 07:00

RNS Number : 8955Y
Accrol Group Holdings PLC
28 August 2018
 

For release: 28 August 2018 at 07:00 am

 

Accrol Group Holdings plc("Accrol" or the "Company")BOARD AND SENIOR MANAGEMENT CHANGES

 

Board Changes

 

Accrol Group Holdings plc (AIM:ACRL), the AIM-listed leading independent tissue converter, is pleased to announce that Euan Hamilton has been appointed Independent Non-Executive Director with immediate effect. Euan replaces Stephen Hammett, who has today stepped down from the Board as Non-Executive Director. The Board thanks Steve and wishes him well as he leaves the Company to pursue other interests.

 

Euan is an international finance executive with over 35 years' experience. Much of his career was spent at the Royal Bank of Scotland Group, until his retirement in 2011, during which time he held numerous roles, chiefly within the Leveraged Finance Division and latterly as Deputy CEO of the Non-Core Division.

 

In 2013, Euan joined Bank of Cyprus Group as Director in the group's Restructuring and Recoveries Division, a role he held until 2015. He is currently a consultant for Bank of Cyprus and a non-executive director of the UK plc subsidiary.

 

The Board now comprises:

· Dan Wright, Executive Chairman;

· Gareth Jenkins, Chief Executive Officer;

· Steve Townsley, Chief Financial Officer;

· Joanne Lake, Independent Non-Executive Director; and

· Euan Hamilton, Independent Non-Executive Director.

 

Dan Wright, Executive Chairman of Accrol, said: "Euan is a finance professional of high standing, with clarity of thought, high standards and independence of mind. He appreciates the rigours of a turnaround situation and the demands of a restructuring from an operational perspective. I am sure the Board and business will benefit from his straight-forward objectivity and unremitting focus."

 

"On behalf of the Board, I welcome Euan to the business and look forward to his contribution."

 

Senior Management Changes

 

Accrol also announces that Mark Dewhurst, currently Operations Director of DS Smith Packaging in Northern Europe, has agreed join the Group as Chief Operating Officer from the 1st September 2018.

 

Mark's career at DS Smith spans nine years, during which he has gained significant experience in transformational change and Operational Excellence and has track record for delivering sustainable performance improvement, through strategic planning, leadership and communication skills.

 

Mark will take over the role of COO from Don Coates, who joined Accrol in October 2017 to assist in the early stages of the Group's turnaround. Don will leave Accrol to take up a CEO role, following an orderly handover.

 

Gareth Jenkins, Chief Executive Officer, said: "It is a statement of how much progress we have made that Accrol is able to attract an operational leader of Mark's capability. We look forward to the knowledge and operational experience he will bring to the business, as we continue to progress the turnaround and establish Accrol as the leader in the industry."

 

"On behalf of the Board, I would like thank Don for his support over the past nine months and dedication to helping us secure a successful turnaround for the business."

 

Information on Euan Hamilton required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

 

Euan Hamilton, aged 57, is currently a director of the following companies:

· Bank of Cyprus UK Limited

· Cramond Capital Partners Limited

· Packall Limited

· Nicosia Mall Property (NMP) Limited

· Nicosia Mall Management (NMM) Limited

· Nicosia Mall Finance (NMF) Limited

· Nicosia Mall Holdings (NMH) Limited

 

In addition, Euan has held the following directorships in the past five years:

· Iperi Properties Limited

 

Euan has no interests in the share capital of Accrol Group Holdings plc.

 

There is no further information on Euan required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

 

Steve Townsley, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Llew Angus (langus@belvederepr.com)

Tel: +44 (0) 7407 023 147

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

 

Accrol operates from three sites:

 

· A manufacturing, storage and distribution facility in Blackburn;

· A facial tissue plant, also in Blackburn; and

· A manufacturing, storage and distribution facility in Leyland.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOASEUFEWFASEIA
Date   Source Headline
22nd May 20186:25 pmRNSPosting of Cricular
22nd May 20187:00 amRNSOpen Offer
22nd May 20187:00 amRNSTR1
15th May 20185:16 pmRNSPosting of Circular
15th May 20183:08 pmRNSProposed Placing to raise £8 million
3rd May 20187:00 amRNSHolding(s) in Company
1st May 20182:06 pmRNSSecond Price Monitoring Extn
1st May 20182:00 pmRNSPrice Monitoring Extension
1st May 20187:00 amRNSRevised Banking Arrangements & Operational Update
4th Apr 20185:06 pmRNSDirector Shareholding
29th Mar 20183:26 pmRNSTR1: Standard form
29th Mar 20187:00 amRNSTR-1: Standard form
27th Mar 20183:43 pmRNSStatement re Share Price Movement
26th Mar 20184:41 pmRNSSecond Price Monitoring Extn
26th Mar 20184:35 pmRNSPrice Monitoring Extension
21st Mar 201812:32 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSTrading Update
15th Feb 20185:55 pmRNSDirector/PDMR Shareholding
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20184:31 pmRNSDirector/PDMR Shareholding
5th Feb 20187:00 amRNSBoard Changes
23rd Jan 20181:16 pmRNSPDMR Dealings
22nd Jan 20187:01 amRNSInterim Results for six months ended 31 Oct 2017
22nd Jan 20187:00 amRNSBoard Change
17th Jan 20183:25 pmRNSUpdate on Health and Safety Incident
4th Jan 20187:00 amRNSTR-1: Standard form
3rd Jan 20187:00 amRNSNotice of Half Year Results
13th Dec 201710:57 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSHolding(s) in Company
11th Dec 20178:02 amRNSDirectors' Dealings
11th Dec 20178:01 amRNSPlacing Shares Admitted
8th Dec 201711:09 amRNSResult of General Meeting
30th Nov 20177:00 amRNSReplacement - TR-1
29th Nov 20172:05 pmRNSTR-1: Standard form
21st Nov 20174:40 pmRNSSecond Price Monitoring Extn
21st Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20177:00 amRNSPosting of Circular
20th Nov 20177:30 amRNSRestoration - Accrol Group Holdings Plc
20th Nov 20177:00 amRNSProposed Placing of £18m and Lifting of Suspension
12th Oct 20174:05 pmRNSUpdate on Health and Safety incident
9th Oct 20177:00 amRNSUpdate on Suspension of Trading on AIM
5th Oct 20177:30 amRNSSuspension - Accrol Group Holdings Plc
5th Oct 20177:00 amRNSTrading Update and Temporary Suspension of Trading
22nd Sep 20172:47 pmRNSResult of AGM
19th Sep 20173:16 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSAppointment of Chief Executive and Trading Update
10th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM (Replacement)
9th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM - Date change
10th Jul 20177:01 amRNSAppointment of Joint Corporate Broker
10th Jul 20177:00 amRNSPreliminary results for year ended 30 April 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.